secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2022-09-22T23:59:59+00:00
Accession:  0001193125-22-249225
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Corcept extends exclusive specialty pharmacy agreement for Korlym with Optime to March 2024
--------------------------------------------------------------------------------

- Amendment extends Optime's exclusive dispensing services for Korlym to March 31, 2024.
- No financial terms disclosed; original agreement from August 2017.
- Optime remains sole specialty pharmacy for Korlym in the United States.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/0001193125-22-249225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/d325698d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-249225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer